<DOC>
	<DOCNO>NCT02259790</DOCNO>
	<brief_summary>Study investigate relative bioavailability fixed-dose combination tablet vs. mono-components telmisartan amlodipine</brief_summary>
	<brief_title>Bioavailability Telmisartan/Amlodipine Fixed-dose Combination Compared Its Mono-components Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( blood pressure , pulse rate body temperature ) , 12lead ECG , clinical laboratory test , find clinical relevance , evidence clinically relevant concomitant disease 2 . Age ≥20 Age ≤35 year 3 . Body weight ≥50 kg 4 . BMI ≥17.6 BMI ≤26.4 kg/m2 ( Body Mass Index ) 5 . Signed date write informed consent prior admission study accordance Good Clinical Practice 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 3 . Chronic relevant acute infection 4 . Any clinical relevant finding laboratory test deviate normal 5 . Positive result hepatitis B antigen , anti hepatitis C virus anti body , syphilitic test HIV test 6 . Surgery gastrointestinal tract ( except appendectomy ) 7 . History relevant orthostatic hypotension ( mean stand systolic blood pressure ( SBP ) vary ≥20 mmHg mean supine SBP mean stand diastolic blood pressure ( DBP ) vary ≥10 mmHg mean supine DBP ) , faint spell blackouts 8 . History hepatic dysfunction ( e.g . biliary cirrhosis , cholestasis ) 9 . History serious renal dysfunction 10 . History bilateral renal artery stenosis renal artery stenosis solitary kidney 11 . History cerebrovascular disorder 12 . History hyperkalemia 13 . Known hypersensitivity component formulation , angiotensin II receptor antagonist , angiotensin convert enzyme dihydropyridine 14 . Intake drug long halflife ( ≥24 hour ) within least one month le 10 halflives respective drug prior administration trial 15 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 7 day prior administration trial 16 . Participation another trial investigational drug within 4 month 6 halflives investigational drug prior administration 17 . Smoker ( ≥20 cigarettes/day ) 18 . Alcohol abuse ( 60 g ethanol/day : ex . 3 middlesized bottle beer , 3 gous ( equivalent 540 mL ) sake ) 19 . Drug abuse 20 . Blood donation ( 100 mL within 4 week prior administration trial ) 21 . Excessive physical activity ( within 1 week prior administration trial ) 22 . Intake alcohol within 2 day prior administration 23 . Inability comply dietary regimen study centre 24 . Intake drugs/supplements ingredient hypericum perforatum citrus fruit ( e.g . grapefruit , Sevilla orange ) within 5 day prior administration 25 . Inability refrain smoke trial day 26 . Any volunteer , principal investigator sub investigator would allow participate study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>